NLRP3 and Alzheimer disease: Second, in vitro blockade of microglial amylin receptors, which we have shown to reduce recruitment of the inflammasome, NLRP3, and the secretion of pro-inflammatory cytokines14, explains our observations of attenuation of neuroinflammatory markers consequent to R5 administration in 5XFAD AD mice.